Condition
Adrenal Suppression
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 4 (1)
Trial Status
Completed2
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03514589Phase 2RecruitingPrimary
NeSST2: The Development of a Noninvasive Short Synacthen Test
NCT01209507CompletedPrimary
Prevalence Study of Adrenal Suppression After Corticosteroids During Chemotherapy
NCT02111265Phase 4UnknownPrimary
THe Comparison of Target Controlled Infusion of Propofol or Etomidate at General Anesthesia in Geriatric Patients
NCT01799408CompletedPrimary
Intra-articular Betamethasone and the Hypothalamic-pituitary-adrenal Axis
Showing all 4 trials